Hydroxyzine Pamoate Oral Capsules Market

Vistaril is used as a sedative to treat anxiety and tension. Vistaril is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system.

Hydroxyzine Pamoate Oral Capsules Market contains market size and forecasts of Hydroxyzine Pamoate Oral Capsules in global, including the following market information:

Global Hydroxyzine Pamoate Oral Capsules Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hydroxyzine Pamoate Oral Capsules Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hydroxyzine Pamoate Oral Capsules companies in 2021 (%)

The global Hydroxyzine Pamoate Oral Capsules market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

25mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydroxyzine Pamoate Oral Capsules include Pfizer, Teva, Amneal, Avet, Mylan, Sandoz, Heritage Pharmaceuticals, KvK-Tech and Barr Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hydroxyzine Pamoate Oral Capsules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydroxyzine Pamoate Oral Capsules Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyzine Pamoate Oral Capsules Market Segment Percentages, by Type, 2021 (%)

• 25mg
• 50mg

Global Hydroxyzine Pamoate Oral Capsules Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyzine Pamoate Oral Capsules Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Hydroxyzine Pamoate Oral Capsules Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyzine Pamoate Oral Capsules Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hydroxyzine Pamoate Oral Capsules revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hydroxyzine Pamoate Oral Capsules revenues share in global market, 2021 (%)
• Key companies Hydroxyzine Pamoate Oral Capsules sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Hydroxyzine Pamoate Oral Capsules sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Teva
• Amneal
• Avet
• Mylan
• Sandoz
• Heritage Pharmaceuticals
• KvK-Tech
• Barr Pharmaceuticals